References
Arbouw MEL, Movig KLL, Guchelaar H-J, Poels PJE, van Vugt JPP, Neef C, Egberts TC (2008) Discontinuation of ropinirole and pramipexole in patients with Parkinson’s disease: clinical practice versus clinical trials. Eur J Clin Pharmacol 64:1021–1026
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481
Cox DR (1972) Regression models and life tables. J Roy Stat Soc 34:187–220
Weiner WJ, Factor SA, Jankovic J (2001) The long-term safety and efficacy of pramipexole in advanced Parkinson’s disease. Parkinsonism Relat Disord 7:115–120
Möller JC, Oertel WH, Köster JK, Pezzoli G, Provinciali L (2005) Long-term efficacy and safety of pramipexole in advanced Parkinson’s disease: results from a European multicenter trial. Mov Disord 20:602–610
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keränen, T., Tuhkasaari, M. & Kuusisto, H. Long-term retention rate of pramipexole in the treatment of Parkinson’s disease. Eur J Clin Pharmacol 65, 955–956 (2009). https://doi.org/10.1007/s00228-009-0661-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0661-4